Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Germ Cell and Embryonal » Neuroectodermal Tumors » Neuroendocrine Tumors
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Nerve Tissue » Neuroectodermal Tumors » Neuroendocrine Tumors
Description
Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition. MeSH
Hierarchy View
Subtype Terms (9)
Apudoma
1 approved drug
Carcinoid Tumor
47 drugs (30 approved, 17 experimental)
Carcinoma, Neuroendocrine
60 drugs (37 approved, 23 experimental)
Melanoma
1208 drugs (289 approved, 919 experimental)
Neurilemmoma
4 approved drugs
Paraganglioma
40 drugs (26 approved, 14 experimental)
Phase 3 Indicated Drugs (20)
Phase 2 Indicated Drugs (82)
Phase 1 Indicated Drugs (27)
Other Experimental Indicated Drugs (11)
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (38)
European Neuroendocrine Tumor Society
European Organisation for Research and Treatment of Cancer
Excel Diagnostic Imaging Clinics
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Grupo Espanol de Tumores Neuroendocrinos (GETNE)
Katholieke Universiteit Leuven
Organization Involved with Phase 2 Indications (140)
Academic and Community Cancer Research United
Association of Patients and Supporters of Neuroendocrine Tumors, Warsaw, Poland
Australasian Gastro-Intestinal Trials Group
Case Western Reserve University
Chinese Academy of Medical Sciences
Diagnostic and Therapeutic Center Gammed
Eastern Cooperative Oncology Group
ECOG-ACRIN Cancer Research Group
Hellenic Cooperative Oncology Group
Hospital Universitario Central de Asturias
Hospital Universitario de León
Instituto do Cancer do Estado de São Paulo
Intergroupe Francophone de Cancerologie Thoracique
Istituto Nazionale per lo Studio e la Cura dei Tumori
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
King Faisal Specialist Hospital
Maria Sklodowska Curie Children's Hospital
Molecular Insight Pharmaceuticals
National Comprehensive Cancer Network
National Institutes of Health (NIH)
Olivia Newton-John Cancer Research Institute
People's Liberation Army of China
State University of New York, Buffalo
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
Universidad Complutense de Madrid
University Hospital Virgen de las Nieves
Organization Involved with Phase 1 Indications (26)
Organization Involved with Other Experimental Indications (10)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.